We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Monitoring Technology Keeps COVID-19 Vaccines Safe

By HospiMedica International staff writers
Posted on 01 Dec 2020
An automated environmental monitoring platform can help administrators prepare for the pending global rollout of COVID-19 vaccines.

The Primex (Lake Geneva, WI, USA) OneVue Sense sensor incorporates a cryogenic probe that can monitor storage units for temperatures as low as minus 200 degrees Celsius. More...
Once paired with the OneVue Monitor automated monitoring software solution, the integrated system provides real-time alerts if vaccine storage temperatures fluctuate outside of the specified temperature range, helping maintain vaccine safety and effectiveness. The system also archives all recorded temperatures to ensure compliance.

In addition to environmental temperature monitoring, the OneVue monitoring software also provides indoor air quality data, differential pressure reading, and contact closure monitoring solutions, which can be used to monitor hospital isolation rooms and to ensure that freezer storage doors remain closed. The cloud-based software powering the OneVue system is fully customizable, enabling users to schedule reports, alerts, and messaging to suit specific needs, and to synchronize many different types of devices across a facility.

“For nearly 50 years, healthcare providers have trusted Primex to deliver proven and reliable healthcare solutions. We are proud to be part of this monumental public health effort to ensure safe, reliable, and effective COVID-19 vaccines reach the public,” said Paul Shekoski, CEO of Primex. “Any breach in temperature control can degrade a vaccine, making it lose its full potency. With the Primex OneVue platform, customers have peace of mind knowing that the vaccine will always remain at the proper temperature.”

The current leading COVID-19 vaccine candidates are expected to require extremely cold storage temperatures, with some, such as the Pfizer (New York, NY, USA) candidate, requiring storage and triage at temperatures as low as minus 70 degrees Celsius.

Related Links:
Primex
Pfizer



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.